GSK CEO Andrew Witty to Retire

GlaxoSmithKline said Andrew Witty would retire as chief executive in March 2017 after roughly 10 years as CEO of the drug maker.

from WSJ.com: US Business http://ift.tt/21wpqCn
via IFTTT